Early Switch and Early Discharge Opportunities in Intravenous Vancomycin Treatment of Suspected Methicillin-Resistant Staphylococcal Species Infections

BACKGROUND: Patients with methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase negative staphylococci (MR-CoNS) infections are usually treated with intravenous (IV) vancomycin and remain hospitalized for the duration of IV therapy. Oral linezolid has excellent bioav...

Descripción completa

Detalles Bibliográficos
Autores principales: Parodi, Stephen, Rhew, David C., Goetz, Mathew Bidwell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2003
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437249/
https://www.ncbi.nlm.nih.gov/pubmed/14613450
http://dx.doi.org/10.18553/jmcp.2003.9.4.317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437249/
https://www.ncbi.nlm.nih.gov/pubmed/14613450
http://dx.doi.org/10.18553/jmcp.2003.9.4.317

Ejemplares similares